Gossamer Bio, Inc. GOSS
11.23 USD -0.20 (-1.75%)
Regular-session close
11.41 +0.18 +1.60%
After hours · Nov 19, 4:00 PM ET
10.80 Day range 11.85
8.29 52-week range 309.60
- YTD
- -95.47%
- 1 year
- -95.53%
GOSS revenue history
Revenue is income from the company’s ordinary business activities.
48,471,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 48,471,000 | -66,230,000 | -57.74% |
| FY 2024 | 2024-12-31 | 114,701,000 | 114,701,000 | Not meaningful |
| FY 2023 | 2023-12-31 | 0 | 0 | Not meaningful |
| FY 2022 | 2022-12-31 | 0 | 0 | Not meaningful |
| FY 2021 | 2021-12-31 | 0 | 0 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-09-13T06:02:00.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
